Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (511-520 of 636) with videos related to

Pageof 64
Sort By:
Cell Metabolism|November 5, 2024
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisXiang Zhang, Ming-Hua Zheng, Dehua Liu, et al.
Nature Chemical Biology|October 18, 2018
Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissuesMartina Wallace, Courtney R Green, Lindsay S Roberts, et al.
Radiology|September 12, 2017
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-AnalysisTakeshi Yokoo, Suraj D Serai, Ali Pirasteh, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Hepatology Communications|October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Nature Medicine|September 7, 2023
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitisArun J Sanyal, Sudha S Shankar, Katherine P Yates, et al.
Nature Genetics|February 4, 2022
Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohortYouwen Qin, Aki S Havulinna, Yang Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
Pageof 64

Showing results (511-520 of 636) with videos related to

Sort By:
Pageof 64
Cell Metabolism|November 5, 2024
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisXiang Zhang, Ming-Hua Zheng, Dehua Liu, et al.
Nature Chemical Biology|October 18, 2018
Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissuesMartina Wallace, Courtney R Green, Lindsay S Roberts, et al.
Radiology|September 12, 2017
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-AnalysisTakeshi Yokoo, Suraj D Serai, Ali Pirasteh, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
Hepatology Communications|October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Nature Medicine|September 7, 2023
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitisArun J Sanyal, Sudha S Shankar, Katherine P Yates, et al.
Nature Genetics|February 4, 2022
Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohortYouwen Qin, Aki S Havulinna, Yang Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
Pageof 64